Cancer treatment has long faced a challenging trade-off: therapies strong enough to eliminate tumors often cause severe side effects. One promising solution involves cytokines, natural proteins that ...

Lung cancer is Australia’s fifth most diagnosed cancer, but causes the greatest number of deaths because it is often ...

ASTRAZENECA is in talks with Summit Therapeutics to license an experimental lung-cancer drug under a deal worth as much as $15 billion, Bloomberg News reported on Thursday, citing people familiar with ...

At just 52 years old, a woman has been diagnosed with Stage 4 lung cancer. A non-smoker who had worked full-time since age 22, she now faces a terminal illness while trying to support her husband and ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

Breast cancer often relapses in distant organs even when complete regression of primary tumors is achieved after initial ...

A study shows for the first time the relationship between this disease and the damage caused to DNA by breathing pollution.

Summit Therapeutics nears a $15B AstraZeneca deal for ivonescimab, targeting a $90B market. See more on the potential and ...

Swedish Match, a subsidiary of Philip Morris International, makes the ZYN pouches. The FDA's approval noted the patches posed ...